André A. Santos

PhD (2015) in Biochemistry (Microbial Biochemistry), Institute of Chemical and Biological Technology (ITQB) António Xavier, Universidade NOVA de Lisboa
Post-Doctoral Fellow, iMed.ULisboa, Faculdade de Farmácia, Universidade de Lisboa

Faculdade de Farmácia, Universidade de Lisboa — Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal

T (+351) 217 946 400
F (+351) 217 946 491
Researcher ID A-3313-2017
Group Researcher ID A-4244-2014
Scopus Author ID 57007586600

Research Interests

André A. Santos aims at understanding how gut microbiota-derived metabolites may impact on liver disease. He focuses his project on diet mice models and correlates results with human samples to identify potential metabolites involved in the onset and progression of non-alcoholic fatty liver disease. Finally, his ultimate goal is to target gut microbiota as a potential new liver disease therapeutic approach.

Selected Publications

Santos AA, Venceslau SS, Grein F, Leavitt WD, Dahl C, Johnston DT, Pereira IA. A protein trisulfide couples dissimilatory sulfate reduction to energy conservation. Science 2015; 350: 1541-5.

Leavitt WD, Bradley AS, Santos AA, Pereira IA, Johnston DT. Sulfur isotope effects of dissimilatory sulfite reductase. Front Microbiol 2015; 6: 1392.

Duarte AG, Santos AA, Pereira IA. Electron transfer between the QmoABC membrane complex and adenosine 5′-phosphosulfate reductase. Biochim Biophys Acta 2016; 1857: 380-6.

Pereira A, Santos A, Tacao M, Alves A, Henriques I, Correia A. Genetic diversity and antimicrobial resistance of Escherichia coli from Tagus estuary (Portugal). Sci Total Environ 2013; 461: 65-71.